Reference: Oldfield, P. R., Hibberd, J., & Bridle, B. W. (2022). How does severe acute respiratory syndrome-coronavirus-2 affect the brain and its implications for the vaccines currently in use. Vaccines, 10(1), 1. https://doi.org/10.3390/vaccines10010001 Summary: This article reviews how SARS-CoV-2 impacts the brain, particularly through its spike protein, which can cross the blood-brain barrier (BBB). Patients […]
Reference: Takuva, S., Takalani, A., Seocharan, I., Yende-Zuma, N., Reddy, T., Engelbrecht, I., Faesen, M., Khutlo, K., Whyte, C., Bailey, V., Trivella, V., Peter, J., Opie, J., Louw, V., Rowji, P., Jacobson, B., Groenewald, P., Dorrington, R. E., Laubscher, R., Bradshaw, D., Moultrie, H., Fairall, L., Sanne, I., Gail-Bekker, L., Gray, G., Gogar, A., Garrett,
Reference: Oldfield, P. R., Hibberd, J., & Bridle, B. W. (2022). How does severe acute respiratory syndrome-coronavirus-2 affect the brain and its implications for the vaccines currently in use. Vaccines, 10(1), 1. https://doi.org/10.3390/vaccines10010001 Summary: The article reviews how SARS-CoV-2 impacts the brain and discusses potential neurological complications tied to COVID-19 and vaccines. The spike protein
Reference: Hatchard, G. (2021, December 17). Relationship between Covid-19 vaccination and all cause mortality. Hatchard Report. https://hatchardreport.com/relationship-between-covid-19-vaccination-and-all-cause-mortality/ Summary: The article by Guy Hatchard investigates the correlation between mRNA Covid-19 vaccinations and all-cause mortality rates in New Zealand, particularly among individuals aged 60 and over. The analysis, facilitated by New Zealand’s unique border controls, allows for
Reference: Neil, M., Fenton, N., Smalley, J., Craig, C., Guetzkow, J., McLachlan, S., Engler, J., & Rose, J. (2021). Latest statistics on England mortality data suggest systematic mis-categorisation of vaccine status and uncertain effectiveness of Covid-19 vaccination. ResearchGate. https://doi.org/10.13140/RG.2.2.14176.20483 Summary: This article scrutinises England’s Covid-19 mortality data, revealing potential systematic mis-categorisation of vaccination status. While
Reference: Palmer, M., & Bhakdi, S. (2021). Long-term persistence of the SARS-CoV-2 spike protein: Evidence and implications. doctors4covidethics.org. Summary: The article by Palmer and Bhakdi examines a study by Bansal et al. that identified the presence of SARS-CoV-2 spike protein in exosomes for up to four months post-vaccination with the Pfizer mRNA vaccine. This prolonged
Reference: Palmer, M., & Bhakdi, S. (2021). Long-term persistence of the SARS-CoV-2 spike protein: Evidence and implications. doctors4covidethics.org. Summary: The article by Palmer and Bhakdi discusses a study by Bansal et al. that reveals the prolonged presence of the SARS-CoV-2 spike protein in individuals vaccinated with the Pfizer mRNA vaccine. It highlights that the spike
Reference: Kampf, G. (2021). The epidemiological relevance of the COVID-19-vaccinated population is increasing. The Lancet Regional Health – Europe, 11, 100272. https://doi.org/10.1016/j.lanepe.2021.100272 Summary: High COVID-19 vaccination rates were anticipated to diminish SARS-CoV-2 transmission; however, recent findings suggest the opposite. In the UK, secondary attack rates among household contacts exposed to fully vaccinated individuals were similar
Reference: Iriarte, I., & Phoenix, S. (2021). Understanding relative risk reduction (RRR) and absolute risk reduction (ARR) in vaccine trials. PANDA. https://www.pandata.org/understanding-relative-risk-reduction-and-absolute-risk-reduction-in-vaccine-trials/ Summary: The article discusses the critical distinctions between Relative Risk Reduction (RRR) and Absolute Risk Reduction (ARR) in the context of vaccine trials, particularly those for COVID-19. RRR compares the efficacy of one
Reference: Campra, P. (2021). Detection of graphene in COVID-19 vaccines by micro-Raman spectroscopy. Technical Report. Almeria, Spain: Universidad de Almería. Summary: This technical report by Professor Pablo Campra investigates the presence of graphene in various COVID-19 vaccine samples using a technique called micro-Raman spectroscopy. The study screened seven vials from four different vaccine brands, identifying